American Oncology Institute (AOI) in Hyderabad Successfully Treats 64-Year-Old Woman with Cervical Cancer Using Advanced Radiotherapy and Interstitial brachytherapy
Hyderabad: American Oncology Institute (AOI) at Citizens Specialty Hospital in Hyderabad, successfully treated a 64-year-old patient diagnosed with advanced cervical cancer. Under the care of Dr Harjot Kaur Bajwa, Radiation Oncologist and Brachytherapy specialist, the patient received radiotherapy along with brachytherapy for precise, internal radiation. The treatment followed a comprehensive and targeted radiotherapy approach, combining daily online adaptive radiotherapy followed by Interstitial Brachytherapy, demonstrating promising results in combating cervical cancer.
Of all cancer types prevalent among women in the Hyderabad district, 8.7 percent are cervical cancer cases. As of early 2024, cervical cancer remains one of the most prevalent cancers affecting women in India, with Telangana witnessing high case numbers, especially in districts such as Adilabad, Khammam, and Medak. Despite cervical cancer being the second most common type of cancer among women after breast cancer, many doctors report that its prevalence is nearly on par with breast cancer, particularly in rural areas.
Mrs. Aruna Shetty (name changed) was diagnosed with locally advanced cervical cancer in September 2023. The disease was very extensive and was blocking one side ureter resulting in urinary obstruction and hydro nephrosis. Given the complexity of her condition, AOI’s multidisciplinary team designed a personalized treatment plan to target the cancer cells while minimizing side effects. “The use of daily adaptive radiotherapy enabled us to take care of the variation in organ movement and adapt to the shrinkage of tumour over time. After completion of external radiation, the residual tumour was destroyed using MRI based interstitial brachytherapy. The use of highly advanced radiotherapy and brachytherapy technology enabled us to achieve a complete response and cure the patient with minimal side effects. The urinary obstruction and hydronephrosis also reversed after tumour shrinkage resulting in excellent quality of life of the patient” said Dr Harjot Kaur Bajwa.
“At AOI, we are committed to delivering cutting-edge cancer treatments that maximize efficacy and improve the quality of life for our patients,” said Harish Trivedi, CEO of CTSI-South Asia. “This case reflects our dedication to offering advanced therapies and the expertise required to manage complex cancer cases in India.”
The treatment process included precise planning and patient comfort measures. The patient underwent multiple imaging procedures to map the cancer’s location accurately, and with the help of advanced technology, the doctors ensured that radiation was targeted precisely, reducing the impact on surrounding tissues.
